Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
8.25
+0.05 (0.61%)
At close: May 3, 2024, 4:00 PM
8.31
+0.06 (0.73%)
After-hours: May 3, 2024, 4:53 PM EDT
Avid Bioservices Revenue
Avid Bioservices had revenue of $136.74M in the twelve months ending January 31, 2024, down -2.81% year-over-year. Revenue in the quarter ending January 31, 2024 was $33.82M, a -11.06% decrease year-over-year. In the fiscal year ending April 30, 2023, Avid Bioservices had annual revenue of $149.27M with 24.81% growth.
Revenue (ttm)
$136.74M
Revenue Growth
-2.81%
P/S Ratio
3.87
Revenue / Employee
$374,616
Employees
365
Market Cap
523.71M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2023 | 149.27M | 29.67M | 24.81% |
Apr 30, 2022 | 119.60M | 23.73M | 24.75% |
Apr 30, 2021 | 95.87M | 36.17M | 60.58% |
Apr 30, 2020 | 59.70M | 6.10M | 11.38% |
Apr 30, 2019 | 53.60M | -18.00K | -0.03% |
Apr 30, 2018 | 53.62M | -4.01M | -6.96% |
Apr 30, 2017 | 57.63M | 13.27M | 29.92% |
Apr 30, 2016 | 44.36M | 17.58M | 65.63% |
Apr 30, 2015 | 26.78M | 4.38M | 19.55% |
Apr 30, 2014 | 22.40M | 718.00K | 3.31% |
Apr 30, 2013 | 21.68M | 6.45M | 42.34% |
Apr 30, 2012 | 15.23M | 1.74M | 12.90% |
Apr 30, 2011 | 13.49M | -14.45M | -51.72% |
Apr 30, 2010 | 27.94M | 9.79M | 53.95% |
Apr 30, 2009 | 18.15M | 12.06M | 197.90% |
Apr 30, 2008 | 6.09M | 2.39M | 64.32% |
Apr 30, 2007 | 3.71M | 515.00K | 16.13% |
Apr 30, 2006 | 3.19M | -1.77M | -35.61% |
Apr 30, 2005 | 4.96M | 1.65M | 49.64% |
Apr 30, 2004 | 3.31M | -607.00K | -15.48% |
Apr 30, 2003 | 3.92M | 155.00K | 4.12% |
Apr 30, 2002 | 3.77M | 2.79M | 284.68% |
Apr 30, 2001 | 979.00K | 929.00K | 1,858.00% |
Apr 30, 2000 | 50.00K | - | - |
Apr 30, 1999 | 0 | - | - |
Apr 30, 1998 | 0 | - | - |
Apr 30, 1997 | 0 | - | - |
Apr 30, 1996 | 3.14M | 3.14M | 42,429.06% |
Apr 30, 1995 | 7.39K | -61.98K | -89.34% |
Apr 30, 1994 | 69.37K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PetIQ | 1.10B |
Orthofix Medical | 746.64M |
CareDx | 280.32M |
Surmodics | 138.20M |
Arbutus Biopharma | 18.14M |
Verve Therapeutics | 11.76M |
Oculis Holding AG | 1.05M |
CDMO News
- 9 days ago - Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 - GlobeNewsWire
- 21 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMO - PRNewsWire
- 6 weeks ago - Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q - GlobeNewsWire
- 7 weeks ago - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors - Business Wire
- 7 weeks ago - Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - Business Wire
- 7 weeks ago - INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors - Business Wire
- 7 weeks ago - The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of Investors - Business Wire
- 2 months ago - CDMO LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Avid Bioservices, Inc. Investors to Inquire About Securities Class Action Investigation – CDMO - Business Wire